Strand gets more cash for mRNA drugs By / On December 1, 2022 / At 11:54 pm / In Chemical world 25 Views The company is developing logic-based mRNA circuitry for a more controlled drug delivery Post navigation Prev PostCannabis research bill clears US Congress Next PostNegotiators tackle first round of talks to control plastic pollution You May Also Like New Jersey sues Dow Chemical and others over 1,4-dioxane pollution On March 28, 2023 | In Chemical world Sentencing delayed again for Harvard’s former chemistry head On March 28, 2023 | In Chemical world Meeting the tigers of the lab On March 28, 2023 | In Chemical world